Durable SARS-CoV-2 antibodies bind to two viral targets at once
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks.
Jan 17, 2023
0
64
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks.
Jan 17, 2023
0
64
The Omicron subvariant XBB.1.5, the most transmissible COVID-19 subvariant so far, is spreading quickly across the United States and was predicted on Friday to become Europe's dominant strain in a matter of weeks.
Jan 13, 2023
0
6
The heavily-mutated omicron variant of SARS-CoV-2, the virus that causes COVID-19, was first detected in late 2021.
Jan 12, 2023
0
8
Vaccines have played a major role in mitigating the harms of the COVID pandemic since their rollout began just over two years ago. They're estimated to have saved tens of millions of lives across the globe.
Jan 11, 2023
0
5
After three years of infections, lockdowns, and vaccinations, we know a lot about SARS-CoV-2, the virus that causes COVID-19—but we don't know everything. Like, why are some variants weaker than others? Why does the omicron ...
Jan 11, 2023
2
73
MUSC Hollings Cancer Center oncologists found that using a combination monoclonal antibody (tixagevimab-cilgavimab) against the SARS-CoV-2 spike protein in patients with blood cancers prevented moderate and severe COVID cases. ...
Dec 16, 2022
0
18
Researchers from the University of Jyväskylä and the Central Finland Health Care District have developed an AI-based neural network to detect an early knee osteoarthritis from X-ray images. AI was able to match doctors' ...
Dec 15, 2022
0
3
Within a study by investigators at Weill Cornell Medicine and NewYork-Presbyterian, the long-term immune response to SARS-CoV-2 mRNA vaccination was similar in pregnant individuals and non-pregnant individuals of reproductive ...
Dec 13, 2022
0
18
A new study in the journal Nature Communications reveals how a viral toxin produced by the SARS-CoV-2 virus may contribute to severe COVID-19 infections.
Dec 9, 2022
1
92
The notorious spike protein of SARS-CoV-2, the virus that causes COVID-19, caused lung cancer cells to die in laboratory studies conducted by researchers at RUSH University Medical Center, who recently published their findings ...
Dec 6, 2022
0
154